陈肇始:政府初步构思免费让全港市民接种疫苗
食物及卫生局局长陈肇始表示,政府初步构思会免费让全港市民接种疫苗,并已预留资金订购两倍香港人口的疫苗,但初期会优先为高风险群组接种,包括医护人员、长者、长期病患者等,预料涉及300万人。
她指,卫生防护中心辖下的科学委员会及专家顾问团正检视通过保密协议,从新型肺炎疫苗研发商取得的疫苗数据资料,并作出评估,包括内地及海外的研发商。
她又指,根据世卫资料,预计疫苗在明年内出现,但供应有限,预计最快明年中、後期才可进行较大规模接种,现时共48款候选疫苗进行临床实验,当中11款进入第3阶段临床实验。
她强调疫情属公共卫生的紧急事故,政府正采取双管齐下策略,为市民采购疫苗,容许使用任何经证明是安全及有效的疫苗,亦不排除有必要时进行紧急立法。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.